Patterns of ocular morbidity among kidney transplant recipients in Ethiopia
DOI:
https://doi.org/10.18203/issn.2454-2156.IntJSciRep20210543Keywords:
Kidney transplant, Immunosuppressive, Morbidity, EthiopiaAbstract
Background: Of all organ transplant procedures renal transplantation has become a very successful and routine procedure. Saint Paul’s Hospital Millennium Medical College is a pioneer and is the only center providing kidney transplant in Ethiopia. Even if this is a life changing and exiting addition to the countries’ health service coverage, its long term outcomes including various complications is not yet assessed. Therefore, the aim of this study is to describe ocular morbidities among kidney transplant recipients in Ethiopia.
Methods: Cross sectional descriptive study was undertaken from October 2017 to December 2018.
Results: There were a total of 135 individuals who underwent renal transplant procedure including 95 (70.4%) male and 40 (29.6 %) female. The median age was 32 years. The cause of renal diseases is not known in majority 112 (83%) of the study subjects. More than 95% of all the study subjects were on multiple immunosuppressant therapy. Of all the individuals examined 128 (94.8%) of them have one or more ocular morbidities. Dry eye 76 (50.7%), optic neuropathies 12 (8%), retinal pigmentary changes 11 (7.3%) and cataract 9 (6%) were frequently observed eye morbidities. There were no significant sight threatening conditions observed in relation to the immunosuppressive therapy or the diseases itself.
Conclusions: Dry eye is the commonest eye morbidity among kidney transplant patients.
Metrics
References
Wang YLQ, Xie JL, QiL, Zhou C, Zhu XR, Ding X, Yang B, Jin P. Analysis of the relationship between postoperative ophthalmic complications and dialysis time of pre-kidney transplantation. Int J Ophthalmol 2012;5(3):370-3.
Shimmyo AMS, Nojima M, Ihara H, Ikoma F. Ocular complications after renal transplantation. Nippon Ganka Gakkai Zasshi 1997;101:220-6.
Pavin CR DA, Cook MD, Chisholm LDJ . Ocular complications in renal transplant recipients. Can Med Assoc J 1977;117:360-2.
Hilton AF. Harrison JD LA, Petrie JJB, Hardie I. Ocular complication in hemodialysis and renal transplantation. Aust J Ophthalmol. 1982;247-53.
Porter R CA, Gardner PS, Uldall RP. Incidence of ocular complications in patients undergoing renal transplantation. Brit Med J. 1972;3:133-6.
Oberman AE CS. Ocular complications in renal transplant recipients. West J Med 1975;123:184-7.
7. Kian-Ersi F TS, Akhlaghi MR. Ocular Disorders in Renal Transplant Patients. Iran J Ophthalmic Res 2007;2(2):23-7.
Coskuncan NM JD, Dunn JP et al.The eye in bone marrow transplantation.IV. Retinal complications. Arch Ophthalmol. 1994;112:372-9.
Openshaw H SN, Smith E. Eye movement disorders in bone marrow transplant patients on cyclosporine and ganciclovir. Bone Marrow Transplant 1997;19:503-5.
Yamani A M-PB, Whitcup SB et al. Visual loss after renal transplantation. Retina 2001;21:553-9.
Reece DE F-LD, Shepard JD. Neurologic complications in allogenic bone marrow transplant patients receiving cyclosporine. Bone Marrow Transplant. 1991;8:393-401.
Guembel HO, Ohrloff C. Opportunistic Infections of the eye in immunocompromised Patients. Ophthalmologica. 1997;211:53-61.
Matsunani C HA, Dyer JA, Rumbach OW, Hardie IR. Ocular complication in renal transplant patient. Aust N Z J Ophthalmol 1994;22:53-7.
Jahadi-hosseini HR, Rahmani B, Karbassi A, Mehrian M, Medghalchi AR. Ocular complication in renal allograft recipients. Transplant Proc 2003;35:309-10.